Incidence of and Risk Factors for Visual Acuity Loss among Patients with AIDS and Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy
- 31 August 2006
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 113 (8) , 1432-1440
- https://doi.org/10.1016/j.ophtha.2006.03.021
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Risk Factors for Mortality in Patients with AIDS in the Era of Highly Active Antiretroviral TherapyOphthalmology, 2005
- Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapyOphthalmology, 2004
- Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapyOphthalmology, 2004
- Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapyAmerican Journal of Ophthalmology, 2002
- Natural History and Outcome of New AIDS-Related Cytomegalovirus Retinitis Diagnosed in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000
- Incidence of Immune Recovery Vitritis in Cytomegalovirus Retinitis Patients following Institution of Successful Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- Long‐Lasting Remission of Cytomegalovirus Retinitis without Maintenance Therapy in Human Immunodeficiency Virus‐Infected PatientsThe Journal of Infectious Diseases, 1998
- Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir ImplantNew England Journal of Medicine, 1997
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989
- The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinomaCancer, 1948